Metsä Group to Invest in Three New Converting Lines at Mariestad’s Tissue Paper mill

Metsä Group’s tissue and greaseproof paper business is investing in three new state-of-the-art converting lines for folded and rolled tissue paper at its mill in Mariestad, Sweden. The investment will enable large scale high quality hand towel production in Scandinavia. In addition it entails efficiency and energy savings as well as improved working environment and safety. The investments are part of the company´s expansion and modernisation investment in Mariestad and strategic Future Mill programme, aimed at world-class environmental and operational performance.

Metsä is investing SEK 4.2 billion (EUR 370 million) in the expansion and modernization of the Mariestad tissue paper mill, and the new converting lines are part of this extensive project. The expansion is focused on sustainable fresh fiber production, where the total share of fresh fiber-based products produced at the mill will be 80 percent after the expansion is completed in the second half of 2025.

Valmet Tissue Converting S.p.A. has been commissioned to deliver two new converting lines to produce rolled tissue papers for the consumer market and C.G Bretting Manufacturing Co., Inc. to deliver one converting line for folded paper towels for professional use.

The new converting lines have a total capacity of 70,000 tons of tissue paper.

"The state-of-the-art converting lines with high-efficiency components ensure optimal performance and productivity. Our converting lines feature highly automated and high-quality rewinding machines, fostering a safer and more efficient working environment. Additionally, the latest folding machine opens doors for us to explore and develop new exciting products, further enhancing our capabilities," says Esa Paavolainen, vice president, Projects, Metsä Tissue.

Metsä's mill in Mariestad produces tissue products sold under the Serla, Lambi and Katrin brands. After the expansion, the mill will have nine converting lines.

The new tissue lines are planned to be commissioned in the second and third quarter of 2025. The parties have agreed not to disclose the value of the investments.

Back to Tissue360 Newsletter